» Articles » PMID: 38576593

Nomogram Based on Multimodal Magnetic Resonance Combined with B7-H3mRNA for Preoperative Lymph Node Prediction in Esophagus Cancer

Overview
Specialty Oncology
Date 2024 Apr 5
PMID 38576593
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Accurate preoperative prediction of lymph node metastasis (LNM) in esophageal cancer (EC) patients is of crucial clinical significance for treatment planning and prognosis.

Aim: To develop a clinical radiomics nomogram that can predict the preoperative lymph node (LN) status in EC patients.

Methods: A total of 32 EC patients confirmed by clinical pathology (who underwent surgical treatment) were included. Real-time fluorescent quantitative reverse transcription-polymerase chain reaction was used to detect the expression of B7-H3 mRNA in EC tissue obtained during preoperative gastroscopy, and its correlation with LNM was analyzed. Radiomics features were extracted from multi-modal magnetic resonance imaging of EC using Pyradiomics in Python. Feature extraction, data dimensionality reduction, and feature selection were performed using XGBoost model and leave-one-out cross-validation. Multivariable logistic regression analysis was used to establish the prediction model, which included radiomics features, LN status from computed tomography (CT) reports, and B7-H3 mRNA expression, represented by a radiomics nomogram. Receiver operating characteristic area under the curve (AUC) and decision curve analysis (DCA) were used to evaluate the predictive performance and clinical application value of the model.

Results: The relative expression of B7-H3 mRNA in EC patients with LNM was higher than in those without metastasis, and the difference was statistically significant ( < 0.05). The AUC value in the receiver operating characteristic (ROC) curve was 0.718 (95%CI: 0.528-0.907), with a sensitivity of 0.733 and specificity of 0.706, indicating good diagnostic performance. The individualized clinical prediction nomogram included radiomics features, LN status from CT reports, and B7-H3 mRNA expression. The ROC curve demonstrated good diagnostic value, with an AUC value of 0.765 (95%CI: 0.598-0.931), sensitivity of 0.800, and specificity of 0.706. DCA indicated the practical value of the radiomics nomogram in clinical practice.

Conclusion: This study developed a radiomics nomogram that includes radiomics features, LN status from CT reports, and B7-H3 mRNA expression, enabling convenient preoperative individualized prediction of LNM in EC patients.

Citing Articles

Value of Computed Tomography Scan for Detecting Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma.

Zeng Y, Liu Y, Li J, Feng B, Lu J Ann Surg Oncol. 2024; 32(3):1635-1650.

PMID: 39586955 DOI: 10.1245/s10434-024-16568-z.


Radiomics in Oesogastric Cancer: Staging and Prediction of Preoperative Treatment Response: A Narrative Review and the Results of Personal Experience.

Garbarino G, Polici M, Caruso D, Laghi A, Mercantini P, Pilozzi E Cancers (Basel). 2024; 16(15).

PMID: 39123392 PMC: 11311587. DOI: 10.3390/cancers16152664.

References
1.
Balachandran V, Gonen M, Smith J, DeMatteo R . Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015; 16(4):e173-80. PMC: 4465353. DOI: 10.1016/S1470-2045(14)71116-7. View

2.
Xu X, Hu H, Su G, Liu H, Hong X, Shi H . Utility of histogram analysis of ADC maps for differentiating orbital tumors. Diagn Interv Radiol. 2016; 22(2):161-7. PMC: 4790068. DOI: 10.5152/dir.2015.15202. View

3.
Han L, Zhu Y, Liu Z, Yu T, He C, Jiang W . Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. Eur Radiol. 2019; 29(7):3820-3829. DOI: 10.1007/s00330-018-5981-2. View

4.
Rice T, Lerut T, Orringer M, Chen L, Hofstetter W, Smithers B . Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Dis Esophagus. 2016; 29(7):715-723. PMC: 5528175. DOI: 10.1111/dote.12513. View

5.
Yip C, Davnall F, Kozarski R, Landau D, Cook G, Ross P . Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. Dis Esophagus. 2014; 28(2):172-9. DOI: 10.1111/dote.12170. View